• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

翻译:肝癌中的翻译后修饰和免疫反应。

Post-translational modifications and immune responses in liver cancer.

机构信息

Academy of Medical Engineering and Translational Medicine, Medical College of Tianjin University, Tianjin, China.

出版信息

Front Immunol. 2023 Jul 11;14:1230465. doi: 10.3389/fimmu.2023.1230465. eCollection 2023.

DOI:10.3389/fimmu.2023.1230465
PMID:37609076
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10441662/
Abstract

Post-translational modification (PTM) refers to the covalent attachment of functional groups to protein substrates, resulting in structural and functional changes. PTMs not only regulate the development and progression of liver cancer, but also play a crucial role in the immune response against cancer. Cancer immunity encompasses the combined efforts of innate and adaptive immune surveillance against tumor antigens, tumor cells, and tumorigenic microenvironments. Increasing evidence suggests that immunotherapies, which harness the immune system's potential to combat cancer, can effectively improve cancer patient prognosis and prolong the survival. This review presents a comprehensive summary of the current understanding of key PTMs such as phosphorylation, ubiquitination, SUMOylation, and glycosylation in the context of immune cancer surveillance against liver cancer. Additionally, it highlights potential targets associated with these modifications to enhance the response to immunotherapies in the treatment of liver cancer.

摘要

翻译后的内容为

翻译后

翻译后内容

翻译后内容

翻译后内容

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5950/10441662/d0c0301374cf/fimmu-14-1230465-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5950/10441662/d0c0301374cf/fimmu-14-1230465-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5950/10441662/d0c0301374cf/fimmu-14-1230465-g001.jpg

相似文献

1
Post-translational modifications and immune responses in liver cancer.翻译:肝癌中的翻译后修饰和免疫反应。
Front Immunol. 2023 Jul 11;14:1230465. doi: 10.3389/fimmu.2023.1230465. eCollection 2023.
2
Intricate effects of post-translational modifications in liver cancer: mechanisms to clinical applications.肝癌中翻译后修饰的复杂作用:从机制到临床应用。
J Transl Med. 2024 Jul 13;22(1):651. doi: 10.1186/s12967-024-05455-6.
3
Unconventional posttranslational modification in innate immunity.先天免疫中的非传统翻译后修饰。
Cell Mol Life Sci. 2024 Jul 6;81(1):290. doi: 10.1007/s00018-024-05319-8.
4
Crosstalk between Ubiquitination and Other Post-translational Protein Modifications in Plant Immunity.泛素化与植物免疫中其他翻译后蛋白修饰的相互作用。
Plant Commun. 2020 Mar 25;1(4):100041. doi: 10.1016/j.xplc.2020.100041. eCollection 2020 Jul 13.
5
Advances in post-translational modifications of proteins and cancer immunotherapy.蛋白质翻译后修饰与癌症免疫治疗的新进展。
Front Immunol. 2023 Aug 22;14:1229397. doi: 10.3389/fimmu.2023.1229397. eCollection 2023.
6
Protein Modification and Autophagy Activation.蛋白质修饰与自噬激活。
Adv Exp Med Biol. 2019;1206:237-259. doi: 10.1007/978-981-15-0602-4_12.
7
Evaluation of post-translational modifications in histone proteins: A review on histone modification defects in developmental and neurological disorders.组蛋白翻译后修饰的评估:组蛋白修饰缺陷在发育和神经紊乱中的研究进展。
J Biosci. 2020;45.
8
Post-translational modification control of RNA-binding protein hnRNPK function.RNA 结合蛋白 hnRNPK 功能的翻译后修饰调控。
Open Biol. 2019 Mar 29;9(3):180239. doi: 10.1098/rsob.180239.
9
The role of protein post-translational modifications in prostate cancer.蛋白质翻译后修饰在前列腺癌中的作用。
PeerJ. 2024 Aug 12;12:e17768. doi: 10.7717/peerj.17768. eCollection 2024.
10
Post-translational modifications in the Protein Data Bank.蛋白质数据库中的翻译后修饰。
Acta Crystallogr D Struct Biol. 2024 Sep 1;80(Pt 9):647-660. doi: 10.1107/S2059798324007794. Epub 2024 Aug 29.

引用本文的文献

1
Lactylation: From Homeostasis to Pathological Implications and Therapeutic Strategies.乳酰化:从体内平衡到病理影响及治疗策略
MedComm (2020). 2025 May 29;6(6):e70226. doi: 10.1002/mco2.70226. eCollection 2025 Jun.
2
Comprehensive analysis of α2,3-sialyltransferases as prognostic biomarkers and immunotherapy targets in kidney renal clear cell carcinoma.α2,3-唾液酸转移酶作为肾透明细胞癌预后生物标志物和免疫治疗靶点的综合分析
Cancer Cell Int. 2025 Feb 7;25(1):36. doi: 10.1186/s12935-025-03640-1.
3
The evolution of S-nitrosylation detection methodology and the role of protein S-nitrosylation in various cancers.

本文引用的文献

1
LncRNA PSCK6-AS1-HIPK2 promotes Th1 differentiation via STAT1 phosphorylation to regulate colitis-related mucosal barrier damage.长链非编码RNA PSCK6-AS1-HIPK2通过信号转导和转录激活因子1磷酸化促进辅助性T细胞1分化,以调节结肠炎相关的黏膜屏障损伤。
Int Immunopharmacol. 2023 Apr;117:109992. doi: 10.1016/j.intimp.2023.109992. Epub 2023 Mar 11.
2
Polyunsaturated Fatty Acid-Bound α-Fetoprotein Promotes Immune Suppression by Altering Human Dendritic Cell Metabolism.多不饱和脂肪酸结合型甲胎蛋白通过改变人树突状细胞代谢促进免疫抑制。
Cancer Res. 2023 May 2;83(9):1543-1557. doi: 10.1158/0008-5472.CAN-22-3551.
3
The Role of PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma Metabolism.
S-亚硝基化检测方法的演变以及蛋白质S-亚硝基化在各种癌症中的作用。
Cancer Cell Int. 2024 Dec 19;24(1):408. doi: 10.1186/s12935-024-03568-y.
4
Puerarin: a hepatoprotective drug from bench to bedside.葛根素:一种从实验室到临床的保肝药物。
Chin Med. 2024 Oct 8;19(1):139. doi: 10.1186/s13020-024-01011-y.
5
Glycerophosphoinositol modulates FGA and NOTCH3 in exercise-induced muscle adaptation and colon cancer progression.甘油磷酸肌醇在运动诱导的肌肉适应和结肠癌进展中调节FGA和NOTCH3。
Front Pharmacol. 2024 Jul 26;15:1430400. doi: 10.3389/fphar.2024.1430400. eCollection 2024.
6
Intricate effects of post-translational modifications in liver cancer: mechanisms to clinical applications.肝癌中翻译后修饰的复杂作用:从机制到临床应用。
J Transl Med. 2024 Jul 13;22(1):651. doi: 10.1186/s12967-024-05455-6.
PI3K/AKT/mTOR 信号通路在肝癌代谢中的作用。
Int J Mol Sci. 2023 Jan 31;24(3):2652. doi: 10.3390/ijms24032652.
4
KRTCAP2 as an immunological and prognostic biomarker of hepatocellular carcinoma.KRTCAP2作为肝细胞癌的免疫和预后生物标志物
Colloids Surf B Biointerfaces. 2023 Feb;222:113124. doi: 10.1016/j.colsurfb.2023.113124. Epub 2023 Jan 2.
5
Elevation of spermine remodels immunosuppressive microenvironment through driving the modification of PD-L1 in hepatocellular carcinoma.精胺通过驱动 PD-L1 的修饰重塑肝癌免疫抑制微环境。
Cell Commun Signal. 2022 Nov 8;20(1):175. doi: 10.1186/s12964-022-00981-6.
6
Association of gut microbiome and primary liver cancer: A two-sample Mendelian randomization and case-control study.肠道微生物群与原发性肝癌的关联:一项两样本孟德尔随机化和病例对照研究。
Liver Int. 2023 Jan;43(1):221-233. doi: 10.1111/liv.15466. Epub 2022 Nov 8.
7
IL-2-mTORC1 signaling coordinates the STAT1/T-bet axis to ensure Th1 cell differentiation and anti-bacterial immune response in fish.IL-2-mTORC1 信号协调 STAT1/T-bet 轴,以确保鱼类 Th1 细胞分化和抗细菌免疫反应。
PLoS Pathog. 2022 Oct 25;18(10):e1010913. doi: 10.1371/journal.ppat.1010913. eCollection 2022 Oct.
8
Global burden of primary liver cancer in 2020 and predictions to 2040.2020 年全球原发性肝癌负担及 2040 年预测。
J Hepatol. 2022 Dec;77(6):1598-1606. doi: 10.1016/j.jhep.2022.08.021. Epub 2022 Oct 5.
9
Harnessing IL-15 signaling to potentiate NK cell-mediated cancer immunotherapy.利用 IL-15 信号转导增强 NK 细胞介导的癌症免疫治疗。
Trends Immunol. 2022 Oct;43(10):833-847. doi: 10.1016/j.it.2022.08.004. Epub 2022 Sep 1.
10
Post-translational modifications on the retinoblastoma protein.视网膜母细胞瘤蛋白的翻译后修饰。
J Biomed Sci. 2022 Jun 1;29(1):33. doi: 10.1186/s12929-022-00818-x.